EPCAM and colorectal carcinoma: The DynarFace offers the synergetic effects of frequent CRC‐interface interaction and accumulatively enhanced magnetic trapping force to improve the capture efficiency toward CRCs with medium EpCAM expression from blood samples by 134.81% and 958.69% compared with non‐dynamic immunoaffinity interface and bulk magnetic separation, respectively.